Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00056134
Status:
COMPLETED
Last Update Posted:
2018-02-19
First Post:
2003-03-06
Brief Title:
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
Sponsor:
University Hospital Erlangen
Organization:
University Hospital Erlangen
Organization Data
Organization:
University Hospital Erlangen
Class:
OTHER
Study ID:
CDR0000270762
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospital Erlangen
Lead Sponsor Class:
OTHER
Responsible Party:
PD Dr med univ Beatrice Schuler-Thurner
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University Hospital Erlangen
Old Name:
None
Old Organization:
None